Ring the bell for a stem cell milestone, specifically for iPS cell work. There’s been a whole lot of commotion about the NEJM article yesterday documenting the experiences of three women with macular degeneration who were blinded by non-FDA approved stem cell eye injections of fat stem cells at a business in Florida, but in the […]
Takahashi team IPS cell vision paper marks major stem cell milestone Read More »
I received a score of great nominations for the Stem Cell Person of the Year 2016 Award and have briefly described the twenty nominees below. The point of the award is to honor the top positive stem cell leader who specifically thinks outside the box and takes risks. I’ve started an on-line vote where you can vote once per day for
20 Nominees for Stem Cell Person of the Year 2016 Award Read More »
The FDA’s stem cell meeting wrapped up today on day two with a diverse group of individual speakers. A series of patient testimonials today in favor of clinics was one thing that stood out. You can read my take of day one and the account of Jeanne Loring who was at the meeting. I’ve noted that on
Report on day 2 of FDA stem cell meeting: patients, researchers, & more Read More »
CIRM announced recently the funding of a number of exciting new studies. ViaCyte received additional funding to support its development of its hESC-based pancreatic progenitor cell product PEC-Direct clinic trials. This work is very promising. CIRM also funded additional diabetes-related research by Humacyte on engineering blood vessels for use in dialysis, which is very creative. I
Stem cell good news: CIRM funds new cutting edge studies Read More »
Something very unusual and positive just happened at this year’s ISSCR meeting. Every year in December I give out an award for the Stem Cell Person of the Year to the individual with the strongest positive impact in the stem cell field generated specifically from outside-the-box thinking and actions. Dr. Jeanne Loring was the recipient in
At ISSCR 2016, $2,000 donation to Summit For Stem Cell patient group Read More »
Some good news today as the pioneering induced pluripotent stem (IPS) cell trial led by Dr. Masayo Takahashi will resume. This clinical study with a focus on macular degeneration has been on hold for quite some time due to regulatory changes in Japan. There had also been concerns over mutations in the 2nd patient’s IPS
Good stem cell news as Masayo Takahashi IPS Cell Trial to Resume Read More »
The REGROW Act would drastically weaken FDA regulation of experimental stem cell therapies. I’ve criticized it in numerous posts (see those here) for its radical ideas that would put patients and the stem cell field at risk. I’m not the only one concerned about it as both ARM and ISSCR oppose it too. Now 10 top patient advocacy
Ten patient groups oppose REGROW Act that would gut stem cell oversight Read More »
The Capitol Times in Wisconsin ran a story just before the primary there on Bernie Sanders on Stem Cells, indicating that has held anti-stem cell research positions. It can sometimes be hard to figure out politicians’ positions on stem cells and what actions they might take. Update: See this poll on what people predicted the
Bernie Sanders Mixed Record on Stem Cells Read More »
What were the top 10 stem cell stories of the year? What were the biggest news and science headlines in the stem cell field in 2015, whether good or bad? Below are mine. What are your top 10 stem cell stories of the past year? Let us know in the comments. Organoids explode. Stem cell-based
Key stem cell stories of the year 2015 Read More »
Congratulations to Dr. Jeanne Loring, the winner of the Stem Cell Person of the Year Award for 2015. Facing steep competition from a very tough field of competitors of finalists, Jeanne came out as the winner for her exceptional contributions in 2015 and throughout her many years in the field. She not only has made
Stem Cell Person of the Year 2015: Jeanne Loring Read More »